The Journal of Pediatrics
Volume 149, Issue 6 , Pages 777-780 , December 2006

The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope

  • Zhang Qingyou, MD
    • ,
  • Du Junbao, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Du Junbao, MD, Department of Pediatrics, Peking University First Hospital, Xi-An Men Street No. 1, West District, Beijing 100034, People’s Republic of China
    • ,
  • Tang Chaoshu, MD

Received 23 March 2006 ,Revised 1 June 2006 ,Accepted 14 July 2006.

References 

  1. Lewis DA, Dhala A. Syncope in pediatric patients. Pediatr Clin North Am. 1999;46:205–219
  2. Mosqueda-Garcia R, Furlan R, Tank J, Femandez-Violante R. The elusive pathophysiology of neurally mediated syncope. Circulation. 2000;102:2898–2906
  3. Perry JC, Garson A. The child with recurrent syncope: autonomic function testing and beta-adrenergic hypersensitivity. J Am Coll Cardiol. 1991;17:1168–1171
  4. Linzer M, Pontinen M, Gold DT, Divine GW, Felder A, Brooks WB. Impairment of physical and psychosocial function in recurrent syncope. J Clin Epidemiol. 1991;44:1037–1043
  5. Massin MM. Neurocardiogenic syncope in children: current concepts in diagnosis and management. Pediatr Drugs. 2003;5:327–334
  6. Brignole M. Randomized clinical trial of neurally mediated syncope. J Cardiovasc Electrophysiol. 2003;14:s64–s69
  7. Salim MA, Di Sessa TG. Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double-blind, placebo-controlled, randomized trial. J Am Coll Cardiol. 2005;45:484–488
  8. Kaufmann H, Saadia D, Voustianiouk A. Midodrine in neurally mediated syncope: a double-blind randomized crossover study. Ann Neurol. 2002;52:342–345
  9. Low P, Gilden JL, Freeman R, Sheng KN, McElligott MA. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. JAMA. 1997;13:1046–1051
  10. Sra J, Maglio C, Biehl M, Dhala A, Blanck Z, Deshpande S, et al. Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard therapy. J Cardiovasc Electrophysiol. 1997;8:42–46
  11. Mitro P, Trejbal D, Rybar R. Midodrine hydrochloride in the treatment of vasovagal syncope. Pacing Clin Electrophysiol. 1999;22:1620–1624
  12. Ward CR, Gray JC, Kenny RA. Midodrine: a role in the management of neurocardiogenic syncope. Heart. 1998;79:45–49
  13. Grubb BP, Karas B, Kosinski D, Boehm K. Preliminary observations on the use of midodrine hydrochloride in the treatment of refractory neurocardiogenic syncope. J Interv Card Electrophysiol. 1999;3:139–143
  14. Samniah N, Sakaguchi S, Lurie KG, Iskos D, Benditt DG. Efficacy and safety of midodrine hydrochloride in patients with refractory vasovagal syncope. Am J Cardiol. 2001;88:80–83
  15. Qingyou Z, Junbao D, Jianjun C, Wangzhen L. Association of clinical characteristics of children with unexplained syncope and the outcome of head-up tilt tests. Pediatr Cardiol. 2004;25:360–364
  16. Stewart JM. Orthostatic intolerance in pediatrics. J Pediatr. 2002;140:404–411
  17. Strieper MJ, Campbell RM. Efficacy of alpha-adrenergic agonist therapy for prevention of pediatric neurocardiogenic syncope. J Am Coll Cardiol. 1993;22:594–597
  18. Zachariah PK, Bloedow PC, Moyer TP. Pharmacodynamics of midodrine, an antihypertensive agent. Clin Pharmacol Ther. 1986;39:586–589
  19. Erhringer H. Studies on the peripheral haemodynamics in man after intravenous infusion of a small dose of di-1-(2’,5’- dimethoxyphenyl) -2-glycinamido-ethanol-(1)-hydrochloride. Int J Clin Pharmacol Ther Toxicol. 1971;4:415–420
  20. Ramsdell CD, Mullen TJ, Sundby GH, Rostoft S, Sheynberg N, Aljunri N, et al. Midodrine prevents orthostatic intolerance associated with simulated spaceflight. J Appl Physiol. 2001;90:2245–2248
  21. Salim MA, Ware LE, Barnard M, Alpert BS, Di Sessa TG. Syncope recurrence in children: relation to tilt-test results. Pediatrics. 1998;102:924–926

 Supported by The National Tenth Five-Year Plan Research Project of China (2004BA720A10) and the Major Basic Research Project of China (2006 CB503807).

PII: S0022-3476(06)00698-6

doi: 10.1016/j.jpeds.2006.07.031

The Journal of Pediatrics
Volume 149, Issue 6 , Pages 777-780 , December 2006

Article Tools